相关实验视频

Updated: Jul 1, 2025

Learning Modern Laryngeal Surgery in a Dissection Laboratory

Learning Modern Laryngeal Surgery in a Dissection Laboratory

Published on: March 18, 2020

林奇综合症:从多学科管理到精确预防

Arianna Dal Buono¹, Alberto Puccini², Gianluca Franchellucci^1,3

¹Department of Gastroenterology, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089 Rozzano, Milan, Italy.

|March 13, 2024

概括

林奇综合征 (LS) 研究进展包括多基因面板测序用于诊断和有希望的预防策略,如阿司匹林和耐药粉. 与LS相关的癌症的个性化治疗和预防正在发展.

科学领域:

遗传学和分子生物学
在瘤学瘤学.
遗传性癌症综合征遗传性癌症综合征

背景情况:

林奇综合征 (LS) 是一种普遍存在的遗传性癌症,占结肠直肠癌的3%.
LS与DNA不匹配修复 (MMR) 缺陷有关,占此类病例的15%.
近年来,我们在了解LS分子致癌方面取得了重大进展.

研究的目的:

审查林奇综合征研究的最新进展.
探索基于基因型的方法来进行LS监测.
检查LS个性化癌症预防和治疗策略.

主要方法:

进行了全面的PubMed搜索.
包括到2023年12月的调查LS分子致癌,监测,预防和治疗的研究.

主要成果:

多基因面板测序是目前的LS诊断标准,用于识别致病性MMR基因变异.
新出现的数据表明,阿司匹林和抗性粉在LS中具有潜在的预防作用.
用免疫性框架转移接种疫苗对LS癌症的治疗和预防有希望.

结论:

目前在结直肠癌患者中怀疑LS的诊断算法是强大的.
对于没有癌症的个人来说,LS查指示的标准化需要改进.
需要对遗传和非遗传因素进行进一步的研究,以便量身定制的LS预防.

关键词:

林奇综合征是什么? 林奇综合征是什么?进行内镜监测.免疫疗法免疫疗法不匹配的维修维修不匹配的维修

更多相关视频

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...